Stock listing
Munich:JX7 Embecta Corp. Aktie
German listing (Munich) of Embecta Corp. · home listing NASDAQ:EMBC
Follow Embecta Corp. into a list and get an email when it puts out news.
Home listing price · NASDAQ:EMBC
$6.02 USD -0.07 (-1.1%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:EMBC
- Day range
- $5.90 – $6.40 USDNov 20, 2026
- Volume
- 862,804 sharesNov 20, 2026
- Market cap
- $341.1M USDAt the close on Nov 20, 2026 · price × 56.66M shares outstanding
- 52-week range
- $2.77 – $14.81 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $5.88M USDMedian day 933,856 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EMBC · Home | $6.02 USD | -0.07 (-1.1%) | 862,804 | $5.97 | $6.40 | $5.90 | $6.09 | Close on Nov 20, 2026 |
| Frankfurt:JX7 | €5.456 EUR | +0.046 (+0.9%) | — | €5.538 | €5.55 | €5.456 | €5.41 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:EMBC · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $6.02 | -0.07 | -1.1% | $5.97 | $6.40 | $5.90 | 862,804 | |
| $6.09 | -0.06 | -1.0% | $6.07 | $6.294 | $5.98 | 716,062 | |
| $6.15 | -0.10 | -1.6% | $6.12 | $6.26 | $6.02 | 933,856 | |
| $6.25 | -0.21 | -3.3% | $6.42 | $6.566 | $6.165 | 947,826 | |
| $6.46 | +0.03 | +0.5% | $6.46 | $6.495 | $6.16 | 566,841 | |
| $6.43 | -0.10 | -1.5% | $6.51 | $6.585 | $6.39 | 973,984 | |
| $6.53 | +0.10 | +1.6% | $6.41 | $6.595 | $6.35 | 721,017 | |
| $6.43 | +0.02 | +0.3% | $6.32 | $6.465 | $6.195 | 804,618 | |
| $6.41 | +0.22 | +3.6% | $6.24 | $6.435 | $6.14 | 604,347 | |
| $6.19 | -0.14 | -2.2% | $6.11 | $6.39 | $5.78 | 623,124 | |
| $6.33 | -0.19 | -2.9% | $6.58 | $6.66 | $6.23 | 780,108 | |
| $6.52 | +0.44 | +7.2% | $6.25 | $6.79 | $6.20 | 1,153,754 | |
| $6.08 | -0.11 | -1.8% | $6.17 | $6.285 | $6.05 | 570,288 | |
| $6.19 | -0.06 | -1.0% | $6.28 | $6.36 | $6.13 | 658,178 | |
| $6.25 | -0.31 | -4.7% | $6.55 | $6.58 | $6.195 | 831,093 | |
| $6.56 | +0.10 | +1.5% | $6.52 | $6.695 | $6.45 | 1,108,544 | |
| $6.46 | -0.09 | -1.4% | $6.54 | $6.60 | $6.371 | 984,993 | |
| $6.55 | -0.25 | -3.7% | $6.80 | $6.895 | $6.49 | 1,277,575 | |
| $6.80 | +0.09 | +1.3% | $6.70 | $6.83 | $6.65 | 679,487 | |
| $6.71 | -0.15 | -2.2% | $6.77 | $6.88 | $6.69 | 717,024 | |
| $6.86 | +0.18 | +2.7% | $6.64 | $6.90 | $6.625 | 922,041 | |
| $6.68 | +0.26 | +4.0% | $6.37 | $6.735 | $6.35 | 706,691 | |
| $6.42 | +0.21 | +3.4% | $6.29 | $6.515 | $6.205 | 746,144 | |
| $6.21 | -0.06 | -1.0% | $6.395 | $6.395 | $6.20 | 899,656 | |
| $6.27 | -0.18 | -2.8% | $6.51 | $6.53 | $6.26 | 622,681 | |
| $6.45 | +0.27 | +4.4% | $6.19 | $6.58 | $6.19 | 983,700 | |
| $6.18 | -0.02 | -0.3% | $6.19 | $6.25 | $6.11 | 651,477 | |
| $6.20 | +0.21 | +3.5% | $6.01 | $6.24 | $5.925 | 732,864 | |
| $5.99 | +0.305 | +5.4% | $5.77 | $6.11 | $5.77 | 1,053,590 | |
| $5.685 | -0.065 | -1.1% | $5.74 | $5.95 | $5.67 | 583,106 | |
| $5.75 | -0.16 | -2.7% | $5.89 | $5.975 | $5.725 | 1,138,972 | |
| $5.91 | -0.04 | -0.7% | $5.86 | $6.16 | $5.86 | 994,131 | |
| $5.95 | +0.07 | +1.2% | $5.90 | $6.145 | $5.80 | 1,205,990 | |
| $5.88 | +0.23 | +4.1% | $5.59 | $5.97 | $5.565 | 1,044,772 | |
| $5.65 | -0.14 | -2.4% | $5.79 | $5.82 | $5.49 | 1,143,216 | |
| $5.79 | +0.13 | +2.3% | $5.735 | $5.955 | $5.65 | 1,048,084 | |
| $5.66 | -0.10 | -1.7% | $5.81 | $5.90 | $5.63 | 1,417,513 | |
| $5.76 | -0.17 | -2.9% | $5.93 | $5.96 | $5.65 | 990,901 | |
| $5.93 | +0.03 | +0.5% | $5.83 | $5.98 | $5.76 | 680,936 | |
| $5.90 | +0.28 | +5.0% | $5.67 | $5.93 | $5.63 | 791,824 | |
| $5.62 | +0.04 | +0.7% | $5.63 | $5.72 | $5.45 | 925,857 | |
| $5.58 | -0.01 | -0.2% | $5.59 | $5.655 | $5.54 | 692,065 | |
| $5.59 | +0.29 | +5.5% | $5.38 | $5.605 | $5.38 | 681,309 | |
| $5.30 | +0.01 | +0.2% | $5.24 | $5.345 | $5.13 | 930,267 | |
| $5.29 | +0.10 | +1.9% | $5.13 | $5.30 | $5.09 | 3,516,915 | |
| $5.19 | +0.06 | +1.2% | $5.18 | $5.215 | $5.072 | 570,883 | |
| $5.13 | +0.04 | +0.8% | $5.09 | $5.29 | $5.09 | 718,227 | |
| $5.09 | -0.15 | -2.9% | $5.21 | $5.285 | $5.035 | 703,339 | |
| $5.24 | +0.30 | +6.1% | $5.00 | $5.30 | $4.98 | 908,749 | |
| $4.94 | +0.05 | +1.0% | $4.93 | $5.036 | $4.89 | 1,133,390 | |
| $4.89 | -0.23 | -4.5% | $5.05 | $5.065 | $4.87 | 1,375,212 | |
| $5.12 | -0.43 | -7.7% | $5.45 | $5.60 | $5.06 | 1,528,205 | |
| $5.55 | -0.25 | -4.3% | $5.71 | $5.76 | $5.475 | 1,361,579 | |
| $5.80 | +0.11 | +1.9% | $5.63 | $5.91 | $5.60 | 1,001,178 | |
| $5.69 | 0.00 | 0.0% | $5.70 | $5.77 | $5.505 | 1,160,095 | |
| $5.69 | +0.44 | +8.4% | $5.27 | $5.695 | $5.27 | 1,301,665 | |
| $5.25 | +0.11 | +2.1% | $5.07 | $5.315 | $5.06 | 2,090,339 | |
| $5.14 | +0.09 | +1.8% | $5.00 | $5.235 | $4.92 | 2,765,941 | |
| $5.05 | +0.08 | +1.6% | $5.03 | $5.179 | $4.99 | 1,473,295 | |
| $4.97 | +0.01 | +0.2% | $4.90 | $5.00 | $4.80 | 952,637 | |
| $4.96 | -0.07 | -1.4% | $4.98 | $5.015 | $4.89 | 817,063 | |
| $5.03 | +0.04 | +0.8% | $4.99 | $5.04 | $4.875 | 1,287,688 | |
| $4.99 | -0.24 | -4.6% | $5.195 | $5.275 | $4.95 | 991,821 | |
| $5.23 | -0.24 | -4.4% | $5.43 | $5.47 | $5.12 | 1,126,878 | |
| $5.47 | +0.05 | +0.9% | $5.32 | $5.625 | $5.32 | 1,624,331 |
- Ticker
- Munich:JX7
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Nov 20, 2026
embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
Latest earnings call · Aug 7, 2026
Embecta (NASDAQ:EMBC) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 7, 2026
Q3 2026 Earnings Presentation
Earnings · 26 slides
Latest news
embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results
Nov 20, 2026
Closed $6.02 (-1.1%) on Nov 20, 2026
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
Aug 7, 2026
Closed $4.42 (+26.3%) on Aug 7, 2026
embecta to Report Fiscal Third Quarter Financial Results
Jul 23, 2026
Closed $3.29 (+1.2%) on Jul 24, 2026
embecta appoints Nimish Muzumdar as SVP and President, North America
Jun 16, 2026
Closed $3.09 (-1.3%) on Jun 16, 2026
embecta Completes Acquisition of Owen Mumford Holdings Limited
May 15, 2026
Closed $3.14 (0.0%) on May 15, 2026
embecta to Participate at the 2026 BofA Securities Global Health Care Conference
May 8, 2026
Closed $3.64 (+1.1%) on May 8, 2026
Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results
May 5, 2026
Closed $3.90 (-57.8%) on May 5, 2026
embecta to Report Fiscal Second Quarter Financial Results
Apr 21, 2026
Closed $9.21 (+0.9%) on Apr 22, 2026
embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited
Mar 19, 2026
Closed $9.12 (+2.9%) on Mar 19, 2026
embecta names new Chairman of the Board and Lead Independent Director
Feb 11, 2026
Closed $10.00 (-0.6%) on Feb 12, 2026
Embecta Corp. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 15 in the last 12 months · 73 in all · newest Nov 20, 2026 · oldest 2022
- Calls
- 18 calls with a replay · 18 with a transcript · latest Aug 7, 2026
- Decks
- 26 decks · latest Aug 7, 2026
Where Embecta Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EMBC · Home listing | NASDAQ | United States | USD |
| gettex:JX7 | gettex | Germany | EUR |
| LS Exchange:A3DGNE | LS Exchange | Germany | EUR |
| Tradegate:JX7 | Tradegate | Germany | EUR |
| BMV:EMBC | BMV | Mexico | MXN |
| BOATS:EMBC | BOATS | United States | USD |
| Lang & Schwarz:A3DGNE | Lang & Schwarz | Germany | EUR |
| BIVA:EMBC | BIVA | Mexico | MXN |
| Frankfurt:JX7 | Frankfurt | Germany | EUR |
| Dusseldorf:JX7 | Dusseldorf | Germany | EUR |
| Munich:JX7 · This page | Munich | Germany | EUR |
| Stuttgart:JX7 | Stuttgart | Germany | EUR |
Valuation
P/E 3.9× against a median of 31.9×: the lowest of 9 Medical devices & supplies companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.58B USD
- P/E
- 3.9×
- EV/sales
- 1.6×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- 59.0%
- Operating margin
- 21.9%
- Net margin
- 8.6%
- Debt to equity
- Negative equity
- Beta vs S&P 500
- 0.74
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Embecta Corp. · NASDAQ:EMBC | US$341.1M | US$1.58B | 3.9× | 1.6× | n/a | n/a | 8.6% | n/a | 0.74 |
| Taidoc Technology Corporation · TWSE:4736 | US$367.6M | US$206.4M | 4.7× | 1.6× | 7.4× | 1.1× | 60.7% | 0.1× | n/a |
| BrainsWay Ltd · TASE:BWAY | US$356.2M | US$299.1M | 35.0× | 4.3× | 26.8× | 4.3× | 14.6% | 0.1× | n/a |
| Star Sports Medicine Co., Ltd Class H · HKEX:1609 | US$347.2M | US$183.4M | 16.9× | 3.0× | 6.8× | 1.8× | 34.0% | 0.0× | n/a |
| COLTENE Holding AG · SIX:CLTN | US$336.6M | US$376.3M | 18.9× | 1.3× | 11.4× | 3.0× | 6.2% | 0.6× | n/a |
| Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290 | US$330.8M | US$220.5M | 29.6× | 3.4× | n/a | 1.0× | 17.2% | 0.1× | n/a |
| ACRO Biomedical Co., Ltd. · TPEX:6748 | US$327.3M | US$299.5M | n/a | 258× | n/a | 10.1× | −216.1% | 0.0× | n/a |
| Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041 | US$325.9M | US$288.8M | 44.4× | 1.2× | 9.7× | 1.1× | 3.0% | 0.1× | n/a |
| Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653 | US$325.8M | US$231.2M | 34.2× | 4.8× | n/a | 2.4× | 19.9% | 0.0× | n/a |
| CapsoVision, Inc. · NASDAQ:CV | US$325.1M | US$304.1M | n/a | 21.9× | n/a | 12.3× | −210.1% | 0.0× | 0.88 |
| NIOX Group PLC · LSE:NIOX | US$318.1M | US$297.0M | 34.7× | 4.7× | 15.3× | 3.7× | 14.4% | 0.0× | n/a |
| Median of the others | US$329.0M | US$292.9M | 31.9× | 3.8× | 10.6× | 2.7× | 14.5% | 0.1× | 0.88 |
Forecasts
3 hold · 1 sell · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 4.00 USD · Analysts' mean
- EPS, year to Sep 2026
- 1.83 · 4 analysts
- Revenue, year to Sep 2026
- 1.02B · 4 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Devdatt Kurdikar | Chairman, President and Chief Executive Officer |
| Nimish Muzumdar | SVP and President, North America |
| Christian GlazarSr | Director, Corporate Communications |
| InvestorsPravesh KhandelwalVP | Head of Investor Relations |
| Pravesh Khandelwal | Sr. Director, Corporate Communications |
Board
| Director | Role |
|---|---|
| Devdatt Kurdikar | Chairman, President and Chief Executive Officer |
| Carrie L. Anderson | Director |
| Christopher R. Reidy | Director |
| Claire Pomeroy | LEAD INDEPENDENT DIRECTOR |
| Karen N. Prange | Director |
| MediaChristian GlazarSr | Director |
| Milton M. Morris | Director |
| Robert J. Hombach | Director |
Events
- Next results
- Nov 24, 2026
Calls
| Call | When | Status |
|---|---|---|
| Embecta (NASDAQ:EMBC) Q4 2026 Earnings Call | Tue, Nov 24, 2026 · 8:00 AM ET | Upcoming |
| Embecta (NASDAQ:EMBC) Q3 2026 Earnings Call | Fri, Aug 07, 2026 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q2 2026 Earnings Call | Tue, May 05, 2026 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q1 2026 Earnings Call | Thu, Feb 05, 2026 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q4 2025 Earnings Call | Tue, Nov 25, 2025 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q3 2025 Earnings Call | Fri, Aug 08, 2025 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q2 2025 Earnings Call | Fri, May 09, 2025 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q1 2025 Earnings Call | Thu, Feb 06, 2025 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q4 2024 Earnings Call | Tue, Nov 26, 2024 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q3 2024 Earnings Call | Fri, Aug 09, 2024 · 8:00 AM ET | Replay |
All 19 calls
| Call | When | Status |
|---|---|---|
| Embecta (NASDAQ:EMBC) Q2 2024 Earnings Call | Thu, May 09, 2024 · 11:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q1 2024 Earnings Call | Fri, Feb 09, 2024 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q4 2023 Earnings Call | Tue, Nov 21, 2023 · 7:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q3 2023 Earnings Call | Tue, Aug 08, 2023 · 11:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q2 2023 Earnings Call | Fri, May 12, 2023 · 11:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q1 2023 Earnings Call | Tue, Feb 14, 2023 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q4 2022 Earnings Call | Tue, Dec 20, 2022 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q3 2022 Earnings Call | Mon, Aug 15, 2022 · 8:00 AM ET | Replay |
| Embecta (NASDAQ:EMBC) Q2 2022 Earnings Call | Fri, May 13, 2022 · 8:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Aug 7, 2026 · Before open | +26.3% |
| Q2 2026 | May 5, 2026 · Before open | −57.8% |
| Q1 2026 | Feb 5, 2026 · Before open | −7.8% |
| Q4 2025 | Nov 25, 2025 | −14.1% |
| Q3 2025 | Aug 8, 2025 · Before open | +18.5% |
| Q2 2025 | May 9, 2025 · Before open | −10.0% |
| Q1 2025 | Feb 6, 2025 · Before open | −2.6% |
| Q4 2024 | Nov 19, 2024 · Before open | −6.5% |
| Q3 2024 | Aug 9, 2024 · Before open | +7.3% |
| Q2 2024 | May 9, 2024 · Before open | +37.9% |
All 19 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Feb 9, 2024 · Before open | −8.5% |
| Q4 2023 | Nov 21, 2023 · Before open | +4.5% |
| Q3 2023 | Aug 8, 2023 · Before open | +2.6% |
| Q2 2023 | May 12, 2023 · Before open | +6.1% |
| Q1 2023 | Feb 14, 2023 · Before open | +12.6% |
| Q4 2022 | Dec 20, 2022 · Before open | −15.6% |
| Q3 2022 | Aug 15, 2022 · Before open | +16.5% |
| Q2 2022 | May 13, 2022 · After close | −4.1% |
| Q1 2022 | Mar 16, 2022 · After close |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 26 slides | Aug 7, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 29 slides | May 5, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 22 slides | Feb 5, 2026 |
| 44th Annual J.P. Morgan Healthcare Conference (January 2026) | Conference | 26 slides | Jan 14, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 24 slides | Nov 25, 2025 |
| Q3 2025 Earnings Presentation | Earnings | 24 slides | Aug 8, 2025 |
| Investor Day (May 2025) | Investor day | 92 slides | May 22, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 26 slides | May 9, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 22 slides | Feb 6, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 25 slides | Nov 26, 2024 |
All 26 decks
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 1.08B | 1.12B | 1.12B | 1.13B | 1.17B | 1.09B |
| Cost of revenue | 403.6M | 387.9M | 370.9M | 354.6M | 364.9M | 322.9M |
| Gross profit | 676.8M | 735.2M | 749.9M | 774.9M | 800.4M | 762.6M |
| Research and development | 37.3M | 78.8M | 85.2M | 66.9M | 63.3M | 61.4M |
| Selling, general and administrative | 332.0M | 365.1M | 341.3M | 294.8M | 240.3M | 214.7M |
| Operating income | 242.1M | 166.8M | 221.5M | 309.6M | 492.0M | 486.5M |
| Depreciation and amortization | 40.7M | 36.2M | 32.6M | 31.7M | 38.3M | 38.3M |
| EBITDA | 282.8M | 203.0M | 254.1M | 341.3M | 530.3M | 524.8M |
| Income before tax | 136.3M | 44.2M | 105.7M | 256.6M | 494.9M | 485.8M |
| Income tax | 40.9M | -34.1M | 35.3M | 33.0M | 80.1M | 58.2M |
| Net income | 95.4M | 78.3M | 70.4M | 223.6M | 414.8M | 427.6M |
| Earnings per share, basic | 1.64 | 1.36 | 1.23 | 3.92 | 7.28 | 7.50 |
| Earnings per share, diluted | 1.62 | 1.34 | 1.22 | 3.89 | 7.28 | 7.50 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 225.5M | 267.5M | 326.3M | 330.9M | 0 | 0 |
| Receivables | 145.6M | 193.0M | 16.7M | 22.2M | 150.6M | |
| Inventory | 178.6M | 171.5M | 152.1M | 122.8M | 118.0M | |
| Current assets | 631.4M | 761.0M | 749.1M | 664.7M | 291.8M | |
| Property, plant and equipment | 451.0M | |||||
| Goodwill | 15.4M | 15.6M | 15.6M | 15.7M | 15.6M | |
| Total assets | 1.09B | 1.29B | 1.21B | 1.09B | 788.0M | |
| Accounts payable | 54.2M | |||||
| Current liabilities | 261.5M | 374.0M | 353.5M | 301.0M | 164.0M | |
| Long-term debt | 1.39B | 1.57B | 1.59B | 1.60B | 0 | |
| Total debt | 1.40B | 1.57B | 1.60B | 1.61B | 0 | 0 |
| Shareholders' equity | -650.6M | -738.3M | -821.7M | -891.4M | 594.3M | 572.2M |
| Shares outstanding | 58.5M | 57.7M | 57.3M | 57.1M | 58.1M | 57.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | 191.7M | 35.7M | 67.7M | 412.2M | 456.3M | 498.5M |
| Capital spending | -9.30M | -15.8M | -26.5M | -23.6M | -36.8M | -41.9M |
| Free cash flow | 182.4M | 19.9M | 41.2M | 388.6M | 419.5M | 456.6M |
| Cash from investing | -9.30M | -15.8M | -26.5M | -24.0M | -39.2M | -41.9M |
| Cash from financing | -226.7M | -73.4M | -48.7M | -48.0M | -417.1M | -456.6M |
| Dividends paid | -35.0M | -34.5M | -34.4M | -8.60M | 0 | 0 |
| Change in cash | -45.6M | -52.3M | -4.40M | 330.9M | 0 | 0 |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 8, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Sep 4, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 11, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Aug 7, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 7, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Aug 7, 2026 | Results | SEC |
| 8-K/A · Current report, amended | Jul 31, 2026 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 8, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jun 2, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 27, 2026 | Big-stake notice | SEC |
| SD · Specialized disclosure | May 22, 2026 | ESG report | SEC |
| 8-K · Current report | May 15, 2026 | Acquisition or disposal | SEC |
| SCHEDULE 13G · Big-stake notice | May 5, 2026 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 1, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 29, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 26, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 19, 2026 | Material contract | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 13, 2026 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Feb 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Feb 5, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 30, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Jan 22, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Dec 18, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Dec 18, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Dec 18, 2025 | Meeting notice | SEC |
| 4/A · Change in ownership, amended | Dec 3, 2025 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 1, 2025 | Insider trade | SEC |
| 10-K · Annual report | Nov 25, 2025 | Annual report | SEC |
| 8-K · Current report | Nov 25, 2025 | Results | SEC |
| 8-K · Current report | Nov 17, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 8, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 18, 2025 | Big-stake notice | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 23, 2025 | Insider trade | SEC |
| 8-K · Current report | May 22, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 9, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2025 | Results | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 25, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 14, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 14, 2025 | Meeting outcome | SEC |
| 144 · Notice of proposed sale | Feb 13, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Feb 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Feb 6, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Dec 19, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Dec 19, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Dec 19, 2024 | Meeting notice | SEC |
| 10-K · Annual report | Dec 11, 2024 | Annual report | SEC |
| 4 · Change in ownership | Dec 4, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 4, 2024 | Insider trade | SEC |
| 8-K · Current report | Dec 2, 2024 | Management or board change | SEC |
| NT 10-K · Late filing notice | Nov 29, 2024 | Explanation request | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2024 | Insider trade | SEC |
| 8-K · Current report | Nov 26, 2024 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 8, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 7, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Oct 25, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| 8-K · Current report | Aug 12, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 9, 2024 | Results | SEC |
| SD · Specialized disclosure | May 28, 2024 | ESG report | SEC |
| 4 · Change in ownership | May 14, 2024 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | May 9, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | May 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| 3/A · Initial statement of ownership, amended | Apr 23, 2024 | Insider trade | SEC |
| 3/A · Initial statement of ownership, amended | Apr 23, 2024 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Apr 9, 2024 | Other filings | SEC |
| 4 · Change in ownership | Apr 8, 2024 | Insider trade | SEC |
| 10-K/A · Annual report, amended | Apr 5, 2024 | Annual report | SEC |
| CORRESP · Letter to the SEC | Apr 5, 2024 | Other filings | SEC |
| 8-K · Current report | Mar 28, 2024 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Mar 28, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 13, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 12, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Feb 12, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Feb 9, 2024 | Insider trade | SEC |
| 8-K · Current report | Feb 9, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Feb 9, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 9, 2024 | Results | SEC |
| SC 13G · Big-stake notice | Jan 30, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 23, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 22, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 22, 2024 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Dec 19, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Dec 19, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Dec 19, 2023 | Meeting notice | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 7, 2023 | Big-stake notice | SEC |
| 10-K · Annual report | Nov 29, 2023 | Annual report | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 28, 2023 | Insider trade | SEC |
| 8-K · Current report | Nov 21, 2023 | Results | SEC |
| SC 13G · Big-stake notice | Sep 13, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 8, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Aug 9, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 8, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2023 | Results | SEC |
| 8-K · Current report | Aug 3, 2023 | Current report | SEC |
| 3 · Initial statement of ownership | Jul 19, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 5, 2023 | Management or board change | SEC |
| SD · Specialized disclosure | May 26, 2023 | ESG report | SEC |
| 4 · Change in ownership | May 12, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | May 12, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2023 | Results | SEC |
| 4/A · Change in ownership, amended | Apr 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 5, 2023 | Insider trade | SEC |
| 4/A · Change in ownership, amended | Feb 16, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 15, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Feb 14, 2023 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 14, 2023 | Results | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Feb 13, 2023 | Meeting outcome | SEC |
| 4 · Change in ownership | Feb 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Feb 10, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2023 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Feb 9, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 8, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 31, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 26, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Jan 20, 2023 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Jan 9, 2023 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Dec 30, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Dec 30, 2022 | Meeting notice | SEC |
| 10-K · Annual report | Dec 22, 2022 | Annual report | SEC |
| 8-K · Current report | Dec 20, 2022 | Results | SEC |
| 4 · Change in ownership | Dec 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 29, 2022 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 10, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Sep 30, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Aug 15, 2022 | Quarterly report | SEC |
This page holds 200 of 262 filings. Open Filings
Cap table
Built by 6ix from Embecta Corp.’s releases · as of Jul 31, 2026
- Common shares
- 56,659,599
- Fully diluted
- 56,659,599
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 56,659,599 | Jul 31, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Jul 31, 2026 | 56,659,599 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert J. Hombach Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Henry Schein, Inc. (Director · Since at least Jan 29, 2025); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past) | Director · Since at least Mar 20, 2022 |
| Karen N. Prange Other companies: Outset Medical, Inc. (Director · Since at least Jan 9, 2026); AtriCure, Inc. (Director · Since at least Dec 4, 2019); Nevro Corp (Director · Dec 17, 2019 – Apr 3, 2025 · Past); Cantel Medical Corp (Director · Oct 28, 2019 – Jun 2, 2021 · Past); Henry Schein, Inc. (EVP&CEO Gl.AH.Med.Den.Sur.Grp · May 17, 2016 – Mar 2, 2018 · Past) | Director · Since at least Apr 1, 2022 |
| Carrie L. Anderson Other companies: The Campbell's Company (Executive Vice President & CFO · Since at least Feb 6, 2023); Integra LifeSciences Holdings Corporation (Executive Vice President & CFO · Jun 24, 2019 – Jul 1, 2022 · Past); Dover Corporation (Vice President and Controller · May 5, 2017 – Mar 15, 2019 · Past) | Director · Since at least Apr 1, 2022 |
| David F Melcher Other companies: Becton, Dickinson and Company (Director · Dec 29, 2017 – Jan 25, 2022 · Past); Exelis Inc (CEO and President, Director · Oct 6, 2011 – May 29, 2015 · Past); ITT Inc. (Senior Vice President · Dec 5, 2008 – Aug 18, 2011 · Past) | Director · Since at least Apr 1, 2022 |
| Claire Pomeroy Other companies: Haemonetics Corporation (Director · Since at least Apr 24, 2019); Becton, Dickinson and Company (Director · Mar 24, 2014 – Jan 25, 2022 · Past) | LEAD INDEPENDENT DIRECTOR · Since at least Apr 1, 2022 |
| Milton Morris Other companies: Nordson Corporation (Director · Since at least Sep 15, 2022); Myomo Inc. (Chair of Technology, Quality and Regulatory Committee · Since at least Jun 9, 2021) | Director · Since at least Apr 1, 2022 |
| Brian Capone Other companies: TrueBlue, Inc. (SVP, Chief Accounting Officer · Since at least Jan 12, 2026) | VP, CAO & Corp. Controller · Nov 26, 2023 – Nov 26, 2023 · Past |
| Christopher R. Reidy Other companies: Encompass Health Corporation (Director · Since at least Apr 15, 2025) | Director · Since at least Feb 11, 2026 |
| Devdatt Kurdikar Other companies: Zimmer Biomet Holdings, Inc. (Director · Since at least Jun 20, 2024) | Chairman, President and Chief Executive Officer · Since at least Apr 1, 2022 |
| Jean Casner Other companies: Cantel Medical Corp (SVP and CHRO · Mar 13, 2019 – Jun 2, 2021 · Past) | Chief Human Resources Officer · Since at least Jul 17, 2023 |
All 25 people
| Person | Seat |
|---|---|
| Jeffrey Z Mann Other companies: Cantel Medical Corp (SVP, General Counsel · Aug 1, 2019 – Jun 2, 2021 · Past) | Pres, Pharm Svc&Prod Mgmt, CLO · Since at least Apr 1, 2022 |
| Ajay Kumar | SVP and CHRO · Apr 1, 2022 – Nov 26, 2022 · Past |
| Anthony M Roth | VP, Chief Accounting Officer · Since at least Nov 26, 2025 |
| Christian GlazarSr | Director, Corporate Communications · Since at least Nov 25, 2025 |
| David Albritton | Director · Apr 1, 2022 – Feb 12, 2025 · Past |
| Gary DeFazio | Director · Feb 10, 2022 – Feb 10, 2022 · Past |
| InvestorsPravesh KhandelwalVP | Head of Investor Relations · Since at least Jan 22, 2026 |
| Jacob Elguicze | SVP and CFO · Since at least Feb 10, 2022 |
| Joseph Frank LaSala | Director · Feb 10, 2022 – Feb 10, 2022 · Past |
| MediaChristian GlazarSr | Director · Since at least Mar 19, 2026 |
| Nimish Muzumdar | SVP and President, North America · Since Jun 15, 2026 |
| Pravesh Khandelwal | Sr. Director, Corporate Communications · Since at least Nov 17, 2025 |
| Pravesh KhandelwalVP | Head of Investor Relations · May 22, 2025 – Nov 5, 2026 · Past |
| Shaun Curtis | SVP, Global Manuf./Sup. Chain · Since at least Apr 1, 2022 |
| Stephanie Kelly | Director · Feb 10, 2022 – Feb 10, 2022 · Past |
Log in to ask 6ix AI your own questions about Embecta Corp.